APA (7th ed.) Citation

RM, M., AM, D., Y, L., C, D., H, L., G, W., . . . SA, G. (2025). CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy. Journal for immunotherapy of cancer, 13(4), . https://doi.org/10.1136/jitc-2025-011549

Chicago Style (17th ed.) Citation

RM, Myers, et al. "CD22-targeted Chimeric Antigen Receptor-modified T Cells for Children and Adults with Relapse of B-cell Acute Lymphoblastic Leukemia After CD19-directed Immunotherapy." Journal for Immunotherapy of Cancer 13, no. 4 (2025). https://doi.org/10.1136/jitc-2025-011549.

MLA (9th ed.) Citation

RM, Myers, et al. "CD22-targeted Chimeric Antigen Receptor-modified T Cells for Children and Adults with Relapse of B-cell Acute Lymphoblastic Leukemia After CD19-directed Immunotherapy." Journal for Immunotherapy of Cancer, vol. 13, no. 4, 2025, https://doi.org/10.1136/jitc-2025-011549.